NeuMoDx CT/NG Assay 2.0
K-Number: K230267 · 2023-12-22
Device Summary
Frequently Asked Questions
What is the NeuMoDx CT/NG Assay 2.0?
NeuMoDx CT/NG Assay 2.0 is a medical device that received FDA 510(k) clearance on 2023-12-22. The listed applicant is Neumodx Molecular, Inc.. The 510(k) number is K230267.
When did NeuMoDx CT/NG Assay 2.0 receive FDA 510(k) clearance?
NeuMoDx CT/NG Assay 2.0 received FDA 510(k) clearance on 2023-12-22, under 510(k) number K230267.
Who is the listed applicant for NeuMoDx CT/NG Assay 2.0?
The FDA 510(k) record lists Neumodx Molecular, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for NeuMoDx CT/NG Assay 2.0?
The FDA product code for NeuMoDx CT/NG Assay 2.0 is QEP.
Other records listing Neumodx Molecular, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: QEP)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.